Seoul, South Korea

Hyo Soo Kim

This inventor holds 7 USPTO granted patents and 6 published patent applications and 4 EPO patents. Top assignees: Seoul National University, Snu Rdb Foundation, Amorepacific Corporation. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyo Soo Kim. Retrieved from https://idiyas.com/inventor/hyo-soo-kim-40lbzfzi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 85.7

 

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Inventor Hyo Soo Kim: Innovations in Biomedicine**

Introduction

Hyo Soo Kim is a renowned inventor based in Seoul, South Korea, recognized for his significant contributions to the field of biomedicine. With a total of six patents to his name, his groundbreaking work focuses on developing innovative therapeutic solutions for various diseases, including inflammatory conditions, cancer, and diabetes.

Latest Patents

Among Hyo Soo Kim’s notable inventions are two critical patents that exemplify his dedication to medical advancement. The first patent involves a polypeptide derived from CAP1, along with a pharmaceutical composition that utilizes this polypeptide as an effective ingredient. This invention aims to address inflammatory diseases, cancer, diabetes, arteriosclerosis, cardiovascular diseases, and heart failure. It showcases the potential to suppress resistin binding to CAP1 and inhibit NF-κB activity, thereby providing therapeutic options for conditions stemming from these pathways.

The second innovative patent pertains to a method for inducing pluripotent stem cells. This method incorporates shikimic acid, a plant extract, for the reprogramming or dedifferentiation of adult cells. By employing ethically sourced plant elements, this procedure alleviates the concerns associated with using embryo-derived cells. The pluripotent stem cells produced from this method can pave the way for immunocompatible cell therapies and offer invaluable insights into disease mechanisms and treatment strategies.

Career Highlights

Hyo Soo Kim has been affiliated with prestigious institutions, such as Seoul National University and the Snur & Db Foundation, where he has conducted extensive research and development in his field. His innovative approaches and scientific rigor have made him a respected figure among peers and have greatly influenced the landscape of biomedical research.

Collaborations

Throughout his career, Hyo Soo Kim has collaborated with noteworthy colleagues, including Eun Ju Lee and Young Bae Park. These partnerships foster an environment of shared knowledge and innovation, contributing to the successful realization of groundbreaking research projects and patented inventions.

Conclusion

Hyo Soo Kim's dedicated pursuit of innovation in the realm of biomedicine through his patents serves as an inspiring example of how scientific inquiry and collaboration can lead to novel therapeutic solutions. His contributions are not only beneficial for advancing medical research but also hold the promise of improving patient outcomes in various critical health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…